Effective long-term treatment with incobotulinumtoxin (Xeomin®) without neutralizing antibody induction: a monocentric, cross-sectional study

BACKGROUND: Among the spectrum of licensed botulinum neurotoxin preparations incobotulinumtoxin (incoBoNT/A; Xeomin®) is the only one which does not contain complex proteins. Therefore, incoBoNT/A has been suggested to have a low antigenicity, but precise estimations on incidence and prevalence of n...

Descripción completa

Detalles Bibliográficos
Autores principales: Hefter, Harald, Brauns, Raphaela, Ürer, Beyza, Rosenthal, Dietmar, Albrecht, Philipp
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2020
Materias:
Original Communication
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7184051/
https://www.ncbi.nlm.nih.gov/pubmed/31960136
http://dx.doi.org/10.1007/s00415-019-09681-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7184051/
https://www.ncbi.nlm.nih.gov/pubmed/31960136
http://dx.doi.org/10.1007/s00415-019-09681-7

Ejemplares similares